TNFRSF18 and neoplasm: Besides targeting the inhibitory receptors of Tregs, costimulatory molecules of Tregs like GITR (glucocorticoid-induced TNF receptor family-related protein) and OX40 can be also used for tumor therapy (Supplementary Table 2).